SUMO and the robustness of cancer.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28134258.
- Also identified by DOI 10.1038/nrc.2016.143.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Post-translational protein modification by small ubiquitin-like modifier (SUMO), termed sumoylation, is an important mechanism in cellular responses to stress and one that appears to be upregulated in many cancers. Here, we examine the role of sumoylation in tumorigenesis as a possibly necessary safeguard that protects the stability and functionality of otherwise easily misregulated gene expression programmes and signalling pathways of cancer cells.
Medical subject headings
- Neoplasms
- SUMO-1 Protein